One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study

Shiratori, Yoshitaka; Brugaletta, Salvatore; Alvarez-Contreras, Luis; Azpeitia, Yajaziel; Ospino, Nestor; Gaido, Sebastian; Delahanty, Anuar; Santos, Alejandro; Martin-Yuste, Victoria; Masotti, Monica; Serruys, Patrick W; Windecker, Stephan; Sabaté, Manel (2013). One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study. Catheterization and cardiovascular interventions, 82(4), E428-E436. Wiley-Blackwell 10.1002/ccd.24897

[img] Text
ccd24897.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (332kB)

OBJECTIVE

to compare the vascular healing process between the sirolimus-eluting NEVO and the everolimus-eluting Xience stent by optical coherence tomography (OCT) at 1-year follow-up.

BACKGROUND

Presence of durable polymer on a drug-eluting metallic stent may be the basis of an inflammatory reaction with abnormal healing response. The NEVO stent, having a bioresorbable polymer eluted by reservoir technology, may overcome this problem.

METHODS

All consecutive patients, who received NEVO or Xience stent implantation between September 2010 and October 2010 in our institution, were included. Vascular healing was assessed at 1-year as percentage of uncovered struts, neointimal thickness (NIT), in-stent/stent area obstruction and pattern of neointima.

RESULTS

A total 47 patients (2:1 randomization, n = 32 NEVO, n = 15 Xience) were included. Eighteen patients underwent angiographic follow-up (eight patients with nine lesions for NEVO vs. 10 patients with 11 lesions for Xience). The angiographic late loss was numerically higher but not statistically different in NEVO compared with Xience treated lesions (0.38 ± 0.47 mm vs. 0.18 ± 0.27 mm; P = 0.171). OCT analysis of 4,912 struts demonstrated similar rates of uncovered struts (0.5 vs. 0.7%, P = 0.462), higher mean NIT (177.76 ± 87.76 µm vs. 132.22 ± 30.91 µm; P = 0.170) and in stent/stent area obstruction (23.02 ± 14.74% vs. 14.17 ± 5.94%, P = 0.120) in the NEVO as compared with Xience.

CONCLUSION

The NEVO stent with a reservoir technology seems to exhibit more neointimal proliferation as compared to Xience stent. The findings of our study, which currently represent the unique data existing on this reservoir technology, would need to be confirmed in a large population.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Windecker, Stephan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1522-1946

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

Judith Liniger

Date Deposited:

24 Mar 2014 09:29

Last Modified:

05 Dec 2022 14:28

Publisher DOI:

10.1002/ccd.24897

PubMed ID:

23441068

Uncontrolled Keywords:

OCT; NEVO; neointima thickness

BORIS DOI:

10.7892/boris.41682

URI:

https://boris.unibe.ch/id/eprint/41682

Actions (login required)

Edit item Edit item
Provide Feedback